Uni-Bio Science Group Limited Announces 2024 Annual Results
- Written by Media Outreach
Record-Breaking Revenue of HK$553.0M and Net Profit of HK$82.8M First-ever Dividend was HK$0.277 Cents Per Share Strengthening Presence in Osteoporosis, Ophthalmology, and Aesthetic Medical Markets
HONG KONG SAR - EQS Newswire - 27 March 2025 - A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited ("Uni-Bio Science",...Read more: Uni-Bio Science Group Limited Announces 2024 Annual Results














